MRK vs SANM · P/E 33, rev $16.61B vs P/E 52, rev $8.13B
Merck & Company Inc (MRK) versus Sanmina Corporation (SANM) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Sanmina Corporation (SANM) is a electronic components company listed on NASDAQ.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported SANM revenue for 2025-09-27 was $8.13B. Net income was $266.3M. SANM currently screens at market cap $13.01B and trailing P/E 51.5.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. SANM currently screens at market cap $13.01B and trailing P/E 51.5.
Not investment advice. Open the MRK and SANM stock pages for the full models.
Not investment advice.